Inland Private Capital Corporation (IPC) has sold two pharmacy portfolios for a combined $80 million.
IPC, through its subsidiary that serves as asset manager, facilitated the sales on behalf of Pharmacy Portfolio III DST and Pharmacy Portfolio IV DST, both structured as zero-cash-flow programs (zeros).
The Pharmacy Portfolio III sale resulted in a total return to investors of 278.10 percent of their original investment, and an average annual return of 16.37 percent. The Pharmacy Portfolio IV sale resulted in a total return to investors of 267.06 percent of their original investment, and an average annual return of 15.08 percent.
These transactions mark IPC’s first full-cycle, zero-cash-flow investment programs. Zero-cash-flow DSTs are an investment vehicle designed to satisfy high debt replacement requirements while also achieving equity growth and capital preservation through ongoing principal paydown of the loan balance. Zeros are typically long-term, tripl
